481 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34935100 | In Vitro Evaluation of P-gp-Mediated Drug-Drug Interactions Using the RPTEC/TERT1 Human Renal Cell Model. | 2022 Mar | 1 |
2 | 35629245 | Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants. | 2022 May 19 | 1 |
3 | 33974505 | Association of polymorphism of CYP3A4, ABCB1, ABCC2, ABCG2, NFKB1, POR, and PXR with the concentration of cyclosporin A in allogeneic haematopoietic stem cell transplantation recipients. | 2021 Jul | 3 |
4 | 34269803 | Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation. | 2021 Oct 28 | 1 |
5 | 31441337 | Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions. | 2020 Feb | 1 |
6 | 32094096 | The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study. | 2020 Apr | 2 |
7 | 32162881 | Severe Anaphylaxis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: Case Report of Individualized Pharmaceutical Care and Literature Review. | 2020 Mar 1 | 1 |
8 | 32222391 | Worsening of Kidney Transplant Function During 2-Year Follow-up Is Associated With the Genetic Variants of CYP3A4, MDR1, and UGT1A9. | 2020 Oct | 1 |
9 | 32682934 | Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies. | 2020 Oct 1 | 2 |
10 | 30690767 | Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantation. | 2019 May | 5 |
11 | 30799432 | Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients. | 2019 Feb 25 | 2 |
12 | 30912163 | Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. | 2019 Jul | 2 |
13 | 31090467 | Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy. | 2019 Dec | 2 |
14 | 31156436 | A Single Dose of Baicalin Has No Clinically Significant Effect on the Pharmacokinetics of Cyclosporine A in Healthy Chinese Volunteers. | 2019 | 2 |
15 | 31261526 | Correlation between gene polymorphism and blood concentration of calcineurin inhibitors in renal transplant recipients: An overview of systematic reviews. | 2019 Jun | 1 |
16 | 29222397 | Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling. | 2018 Mar | 1 |
17 | 29352737 | Bronchiolitis obliterans syndrome is associated with increased p-glycoprotein expression and loss of glucocorticoid receptor from steroid-resistant proinflammatory CD8+ T cells. | 2018 May | 1 |
18 | 29568367 | The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression in vitro. | 2018 Mar 2 | 1 |
19 | 29623717 | [Idiopathic thrombocytopenia refractery to therapy of cyclosporine A in clinical practice - case report]. | Spring 2018 | 1 |
20 | 30109442 | Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules. | 2018 Aug 14 | 1 |
21 | 28214069 | [Pharmacokinetic drug interaction between miconazole mucoadhesive tablet and tacrolimus: About 3 case-reports in transplant patients]. | 2017 Sep | 1 |
22 | 28623111 | Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levels. | 2017 Aug 1 | 1 |
23 | 28736004 | Lack of Association Between TGF-β1 and MDR1 Genetic Polymorphisms and Cyclosporine-Induced Gingival Overgrowth in Kidney Transplant Recipients: A Meta-analysis. | 2017 Jul - Aug | 1 |
24 | 28739698 | Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose. | 2017 Aug | 1 |
25 | 28739760 | Cyclosporin A Reversed Chemoresistance of a Patient with Pure Red Cell Aplasia Secondary to Thymoma. | 2017 Aug | 1 |
26 | 28952408 | Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients. | 2017 Nov | 2 |
27 | 29381954 | Effect of MDR1 C1236T polymorphism on cyclosporine pharmacokinetics: A systematic review and meta-analysis. | 2017 Nov | 4 |
28 | 26353895 | Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir. | 2016 Feb | 1 |
29 | 26563728 | (11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography. | 2016 Jan 5 | 1 |
30 | 26585254 | Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. | 2016 Apr | 1 |
31 | 26912097 | Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. | 2016 | 2 |
32 | 27016408 | Plasma protein binding limits the blood brain barrier permeation of the pyrethroid insecticide, deltamethrin. | 2016 May 27 | 4 |
33 | 27283486 | Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates. | 2016 Aug 25 | 4 |
34 | 27374283 | Changes in ABCB1 mRNA Expression in Peripheral Blood Cells before and after Renal Transplantation. | 2016 | 2 |
35 | 27836711 | Effect of cigarette smoke extract on P-glycoprotein function in primary cultured and newly developed alveolar epithelial cells. | 2016 Dec | 1 |
36 | 28164520 | The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. | 2016 Oct 1 | 1 |
37 | 25240575 | Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients. | 2015 Jan | 7 |
38 | 25407255 | Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants. | 2015 Feb | 1 |
39 | 25536375 | The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis. | 2015 Aug | 9 |
40 | 25673014 | The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients. | 2015 May | 1 |
41 | 25857708 | 2'[(18)F]-fluoroethylrhodamine B is a promising radiotracer to measure P-glycoprotein function. | 2015 Jul 10 | 2 |
42 | 25891084 | Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation. | 2015 Jul | 5 |
43 | 26004871 | Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. | 2015 Aug 1 | 1 |
44 | 26107754 | Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation. | 2015 | 1 |
45 | 26153782 | P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases. | 2015 Oct | 3 |
46 | 26618109 | Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis. | 2015 Nov 20 | 1 |
47 | 27022464 | Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression. | 2015 Dec | 2 |
48 | 24212378 | In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold. | 2014 Feb | 2 |
49 | 24219005 | Phase II and pharmacological study of oral docetaxel plus cyclosporin A in anthracycline pre-treated metastatic breast cancer. | 2014 May | 3 |
50 | 24364805 | Predicting the outer boundaries of P-glycoprotein (P-gp)-based drug interactions at the human blood-brain barrier based on rat studies. | 2014 Feb 3 | 4 |